Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Go back to Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval| Agilent Technologies Inc (NYSE: A) | Delayed: 172.97 -2.58 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $175.55 | 52 Week High | $48.63 | |||
| Open | $175.04 | 52 Week Low | $34.15 | |||
| Day High | $177.47 | P/E | 80.08 | |||
| Day Low | $172.16 | EPS | $2.16 | |||
| Volume | 2,901,102 | |||||
| (NASDAQ: AUTL) | Delayed: 1.60 -0.12 (6.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.72 | 52 Week High | $ | |||
| Open | $1.74 | 52 Week Low | $ | |||
| Day High | $1.74 | P/E | N/A | |||
| Day Low | $1.59 | EPS | $ | |||
| Volume | 2,349,803 | |||||



